BioNTech price target cut to $114 by Morgan Stanley
Morgan Stanley cut its BioNTech price target to $114.00 per share from $115.00, according to ratings actions cited by Benzinga.
Story updates
02:36:08 PM UTC
SquawkNews
BioNTech Price Target Cut to $114.00/Share From $115.00 by Morgan Stanley